Ikarian Capital’s Compass Pathways CMPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
15,000
-660,000
-98% -$6.7M 0.02% 139
2026
Q1
$3.73M Buy
675,000
+275,000
+69% +$1.85M 0.3% 73
2025
Q4
$2.76M Buy
+400,000
New +$2.44M 0.22% 88
2025
Q1
Sell
-202,894
Closed -$767K 180
2024
Q4
$767K Sell
202,894
-14
-0% -$71 0.1% 118
2024
Q3
$1.28M Sell
202,908
-100,000
-33% -$706K 0.18% 88
2024
Q2
$1.83M Buy
+302,908
New +$2.38M 0.32% 59
2021
Q4
Sell
-229,202
Closed -$6.85M 201
2021
Q3
$6.85M Buy
229,202
+144,139
+169% +$4.84M 0.48% 50
2021
Q2
$3.25M Sell
85,063
-140,863
-62% -$5.03M 0.26% 91
2021
Q1
$8.32M Buy
225,926
+202,278
+855% +$8.87M 0.28% 79
2020
Q4
$1.13M Sell
23,648
-129,400
-85% -$5.52M 0.05% 174
2020
Q3
$5.34M Buy
+153,048
New +$5.5M 0.39% 66

Other funds holding CMPS

Ikarian Capital's CMPS Position: Q2 2026 in Review

Ikarian Capital reduced its Compass Pathways (CMPS) stake by 98% in Q2 2026, selling an estimated $6.7M and leaving 15,000 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #139.

Ikarian Capital first reported a position in CMPS in Q3 2020 and has held it in 11 quarters since. The position peaked at $8.32M in Q1 2021. 223 funds tracked by Wall St. Rank hold CMPS as of Q2 2026.

  • Ikarian Capital held 15,000 shares of Compass Pathways worth $212K as of Q2 2026.
  • Ikarian Capital sold 660,000 Compass Pathways shares in Q2 2026, an estimated $6.7M.
  • Compass Pathways made up 0.02% of Ikarian Capital's portfolio in Q2 2026, its #139 holding.
  • Ikarian Capital first reported a position in Compass Pathways in Q3 2020 and has held it in 11 quarters since.
  • Ikarian Capital's Compass Pathways position peaked at $8.32M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Compass Pathways as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.